NCT02293772

Brief Summary

A loss of body weight has been documented in lowland-living individuals when exposed to hypoxic environments, such as at high altitude, or under laboratory conditions. A reduction in appetite and energy intake has also been reported during conditions of microgravity, such as during space flight. Fourteen normal or over-weight men, who are otherwise healthy, will undergo 3x 21-day interventions; normobaric normoxic bed rest (NBR; FiO2=21%), normobaric hypoxic ambulatory confinement (HAMB; FiO2=14%; \~4000 m simulated altitude), and normobaric hypoxic bed rest (HBR; FiO2=14%). The effects of hypoxia and bedrest on appetite and its hormonal control will be assessed before and at day 17 of each intervention using a mixed meal tolerance test.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2012

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 13, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 18, 2014

Completed
Last Updated

March 15, 2019

Status Verified

March 1, 2019

Enrollment Period

1.7 years

First QC Date

November 13, 2014

Last Update Submit

March 13, 2019

Conditions

Keywords

BedrestAppetite

Outcome Measures

Primary Outcomes (1)

  • Postprandial whole blood glucose concentration

    a fasted sample and a sample taken every 10mins for 2hrs following eating, before and after 17days of intervention

    2hrs

Secondary Outcomes (18)

  • Postprandial serum insulin concentration

    2hrs

  • Postprandial serum C-Peptide concentration

    2hrs

  • Fasting serum leptin concentration

    early morning fasted sample

  • Fasting serum adiponectin concentration

    early morning fasted sample

  • Fasting serum total cholesterol concentration

    early morning fasted sample

  • +13 more secondary outcomes

Study Arms (3)

Hypoxic ambulatory

ACTIVE COMPARATOR

Ambulatory in normobaric hypoxia

Other: Hypoxic ambulatory

Hypoxic Bedrest

EXPERIMENTAL

Bedrest in normobaric hypoxia

Other: Hypoxic Bedrest

Normoxic bedrest

ACTIVE COMPARATOR

Bedrest in normobaric normoxia

Other: Normoxic Bedrest

Interventions

21 days confinement in normobaric hypoxic (FiO2 = 14%) environment

Hypoxic ambulatory

21 days supine bedrest in normobaric hypoxic (FiO2 = 14%) environment

Hypoxic Bedrest

21 days supine bedrest in normobaric normoxic (FiO2 = 21%) environment

Normoxic bedrest

Eligibility Criteria

Age25 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physically and mentally healthy subjects
  • Body mass index \< 25 kg/m2
  • Height 158 - 190 cm
  • Waist circumference \< 94 cm
  • Volunteers that are able to declare their willingness to participate in the entire study
  • Willing to be assigned randomly to the three groups
  • Successfully passing the psychological and medical screening
  • competent to sign informed consent
  • Slovenian social insurance
  • English language fluency

You may not qualify if:

  • Medication required that may interfere with the interpretation of the results
  • Bone mineral density (as measured by DEXA) more than 1.5 standard deviations \< t score
  • Recent sub-standard nutritional status
  • Family history of thrombosis or positive response in thrombosis screening procedure.
  • (Biochemical analysis of the following parameters: ATIII, High sensitive C-reactive protein, S-Akt., Factor V-Leiden, Prothrombin, Lupus-partial thromboplastin time, Factor II)
  • History of: thyroid dysfunction, renal stones, diabetes, allergies, hypertension, hypocalcemia, uric acidaemia, lipidaemia, or hyperhomocysteinaemia
  • Gastro-esophageal reflux disease or renal function disorder, Hiatus hernia
  • History of medical illness
  • Smoker within six months prior to the start of the study
  • Abuse of drugs, medicine or alcohol
  • Participation in another study up to two months before study onset
  • No signed consent form before the onset of the experiment
  • Blood donors in the past three months before the onset of the experiment
  • Vegetarian and Vegans
  • Migraines
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Simpson EJ, Debevec T, Eiken O, Mekjavic I, Macdonald IA. PlanHab: the combined and separate effects of 16 days of bed rest and normobaric hypoxic confinement on circulating lipids and indices of insulin sensitivity in healthy men. J Appl Physiol (1985). 2016 Apr 15;120(8):947-55. doi: 10.1152/japplphysiol.00897.2015. Epub 2016 Jan 14.

  • Debevec T, Bali TC, Simpson EJ, Macdonald IA, Eiken O, Mekjavic IB. Separate and combined effects of 21-day bed rest and hypoxic confinement on body composition. Eur J Appl Physiol. 2014 Nov;114(11):2411-25. doi: 10.1007/s00421-014-2963-1. Epub 2014 Aug 5.

  • Debevec T, Simpson EJ, Mekjavic IB, Eiken O, Macdonald IA. Effects of prolonged hypoxia and bed rest on appetite and appetite-related hormones. Appetite. 2016 Dec 1;107:28-37. doi: 10.1016/j.appet.2016.07.005. Epub 2016 Jul 6.

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Igor Mekjavic, PhD

    Jozef Stefan Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

November 13, 2014

First Posted

November 18, 2014

Study Start

March 1, 2012

Primary Completion

November 1, 2013

Study Completion

October 1, 2014

Last Updated

March 15, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share